Does Helicobacter pylori eradication therapy result in a platelet count improvement in adults with immune thrombocytopenic purpura regardless of H pylori infection? ASH evidence-based review 2008.

scientific article

Does Helicobacter pylori eradication therapy result in a platelet count improvement in adults with immune thrombocytopenic purpura regardless of H pylori infection? ASH evidence-based review 2008. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1182/ASHEDUCATION-2008.1.31
P698PubMed publication ID19074051
P5875ResearchGate publication ID23654949

P50authorRoberto StasiQ124077304
P2093author name stringDonald M Arnold
P407language of work or nameEnglishQ1860
P921main subjectHelicobacter pyloriQ180556
thrombocytopeniaQ585285
eradication of infectious diseasesQ1347969
Immune thrombocytopenic purpuraQ3410984
P304page(s)31-32
P577publication date2008-01-01
P1433published inHematology / the Education Program of the American Society of HematologyQ26842068
P1476titleDoes Helicobacter pylori eradication therapy result in a platelet count improvement in adults with immune thrombocytopenic purpura regardless of H pylori infection? ASH evidence-based review 2008.

Reverse relations

cites work (P2860)
Q38861659A localized case-control study of extra-gastric manifestations of Helicobacter pylori infection in children.
Q33400911An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP).
Q54203358Helicobacter pylori Infection in Pediatric Patients: Update on Diagnosis and Eradication Strategies.
Q33415361Helicobacter pylori infection & immune thrombocytopenic purpura in children and adolescents: A randomized controlled trial
Q33413202Poor platelet Count Response to Helicobacter Pylori Eradication in Patients with Severe Idiopathic Thrombocytopenic Purpura
Q33395943Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients: a double-blind, randomized Phase III clinical trial

Search more.